Ethanol, also referred to as ethyl alcohol, grain alcohol, and drinking alcohol, is most commonly known as just alcohol. Ethanol (CH 3 -CH 2 -OH) is a central nervous system depressant produced by the fermentation of carbohydrates from fruits or grains. 1 Alcohol is widely consumed in almost every society. Turkey's annual consumption of alcohol was reported to be 1.4 L/capita. 2 The ingested ethanol is readily absorbed from the gastrointestinal tract and directly reaches the liver without the need for any carriers. Ethanol is degraded via multiple enzymatic pathways, such as alcohol dehydrogenase (ADH), cytochrome P4502E1 (CYP2E1), and catalase. 3, 4 Ethanol that exceeds the liver's metabolizing capacity floods into the systemic circulation. Ethanol acts as a depressant on the brain and other nerve tissues, and its effects are dose dependent. 5 When the blood ethanol level is 20 mg/dL, effects such as euphoria and relaxation are observed, but when the level reaches 50 mg/dL, effects such as hot flashes and lowering of caution begin to appear. When the ethanol level is above 100 mg/dL, significant impairment of motor coordination and loss of good judgment are manifested. Speech may be slurred; balance, vision, reaction time, and hearing will be impaired. Confusion may begin when the ethanol level reaches 200 mg/dL, and stupor or coma are undesirable effects that occur above 400 mg/dL. 6 Interference can be defined as the measurement result of a substance being influenced by another substance present in the specimen. The substance causing the interference may rearrange the structure of the analyte or may change the measurement result by interacting with the reagents used. This change is generally proportional to the concentration of the interfering substance and suggests dose-dependent proportional interference. Sometimes, interference can lead to uncertainty in the measurement result. In that case, the presence of a random error is considered. The interfering agent may be of endogenous or exogenous origin. Endogenous interfering substances are naturally present in the human body but may not be present in the studied sample. Hemolysis (hemoglobin and other substances), bilirubin, lipids, proteins, antibodies (autoantibodies, heterophile antibodies), and excessive analyte concentration are examples of causes of internal origin interference. External interference is caused by substances that should not be naturally present in the person's specimen, including drugs and their metabolites, additives, foods, herbal products, intravenous fluids, and substances used as therapy. 7, 8 Although alcohol is a widely used substance in almost all societies, there is limited knowledge in the literature about its potential interference in biochemical tests.
In our hospital, most requests for ethanol testing are made by emergency services. Biochemical tests play a critical role in clinical decision making in emergency departments; therefore, any false test results that may occur due to ethanol gain even more importance. Whether it is an emergency service or polyclinic patient, delivery of the correct test result to the physician is one of the important tasks of the biochemistry laboratory. Therefore, in this study, we aimed to assess the potential interfering effects of ethanol on routine biochemical tests.
Materials and Methods
This study was performed in stages as described below.
Preparation of Serum Pool
The first question to answer when planning this study was whether it was better to use plasma or serum samples. Although the level of ethanol is measured in the plasma sample, routine biochemical tests are usually performed on serum, so we decided to use serum samples. We reference the EP 7A-2 protocol published by Clinical and Laboratory Standards Institute (CLSI) in the preparation of the serum pool.
9 Blood samples were collected into gel separator tubes (BD Vacutainer SST II Advance; BD, Franklin Lakes, NJ) from patients who consulted our emergency department and were centrifuged at 1,500g for 10 minutes within 30 minutes of being obtained. First, the ethanol level of each individual was measured, and serum pools were prepared from the samples of 20 individuals with an ethanol level below 10 mg/dL.
Creation of Groups With Different Ethanol Levels
The pooled serum was divided into five equal parts. The first group was the ethanol-negative group, and ethanol was added to the other samples so that the final concentration was at the specified level of 50 mg/dL, 100 mg/dL, 200 mg/dL, and 400 mg/dL (ethanol absolute EMPLURA; Merck, Burlington, MA). An equal volume of distilled water was added to the first batch to normalize dilution effects. Thus, five groups were formed with different concentrations of ethanol.
Study of Biochemical Tests
Each pool was divided into 20 equal portions, and biochemical tests were run on each sample. The number of samples per group was calculated according to the CLSI EP 7A-2 protocol. 9 The biochemical tests were carried out with an Olympus AU680 autoanalyzer (Beckman Coulter, Brea, CA) using photometric methods. The tests evaluated in the study and the principle of each test are given in ❚Table 1❚.
Statistical Analysis for Assessment of Possible Interference
The potential effects of ethanol on biochemistry test results were evaluated according to the total allowable error (aTE) recommendations of the Clinical Laboratory Improvement Amendments of 1988 (CLIA 88). 10 It is expected that the calculated total analytical error for each method should not exceed the reported aTE limit.
Total error was calculated as follows 11, 12 :
where TE = total error and CV = coefficient of variation.
Bias was calculated as follows:
where Cneg = mean concentration of the ethanol-negative group and Cpos = mean concentration of the ethanol-positive group.
Recovery of Ethanol Test
At the same time, we were able to calculate the recovery of the ethanol test used in this study. Thereby, verification of the method was performed. Recovery was calculated as follows 11 :
Recovery % = Mean ethanol value of the group Added amount of ethanol l 
Results
The CV, bias, and TE values of each analyte are reported in Table 1 as separate groups. Table 1 summarizes the influence of ethanol on routine biochemistry tests. We have obtained findings suggesting that ethanol can cause interference in urea, direct bilirubin, alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) tests. ❚Figure 1❚ illustrates the TE values of urea, direct bilirubin, ALT, and LDH among the groups.
The recovery % values calculated for the ethanol test are as follows: 100.5% for the group containing 50 mg/ dL ethanol, 95% for the group containing 100 mg/dL ethanol, 105% for the group containing 200 mg/dL ethanol, and 106% for the group containing 400 mg/dL ethanol.
Discussion
The major responsibility of a clinical laboratory is to guide the health professionals in the diagnosis and treatment of patients within today's complex health care system. The value of clinical laboratory test results in making decisions is increasing day by day. In this sense, the production of the correct test result becomes increasingly important. 13 Interference is one of the most important analytical problems of biochemistry. Hemolysis, bilirubin, and lipids are the most common cause of interference. However, it is known that many drugs also cause interference. Ethanol has a depressive effect on the central nervous system, and because of its psychoactive effects, it is considered a drug.
14 Alcohol is probably the most commonly consumed drug. Although it is consumed so commonly, to our knowledge, no study has evaluated the interfering effect of ethanol on routine biochemical tests.
Unlike other nutrients, ethanol is directly absorbed without digestion. Ethanol crosses biological membranes by passive diffusion, down its concentration gradient. 3 Twenty percent of the ingested ethanol is absorbed from the stomach, and the remaining 80% is absorbed from the upper parts of the small intestines. Ethanol reaches the liver directly through the portal system without the need for any carriers. Although the liver is the main organ that metabolizes ethanol, some of the ethanol is also degraded by gastric alcohol dehydrogenases. Most of the ethanol that reaches the liver is converted to acetyl aldehyde by alcohol dehydrogenases using nicotinamide adenine dinucleotide. However, cytochrome P450-2E1 and catalase are other enzymes involved in the oxidative degradation of ethanol. Acetate, produced from oxidation of acetaldehyde by acetaldehyde dehydrogenase, is then oxidized into CO 2 . However, most of the acetate escapes from the liver into the circulation and is metabolized in the heart, skeletal muscle, and brain cells. Nonoxidative metabolism of ethanol is minimal, but it produces toxic molecules called fatty acid ethyl esters. 15 If the amount of ingested ethanol exceeds the metabolizing capacity of the liver, it floods into the systemic circulation. The plasma matrix is water based. Ethanol is a water-soluble substance due to its small size and alcoholic hydroxyl group. Ethanol is first dissolved in the plasma and then diffuses into the tissues. Ethanol in the blood is distributed to the tissues according to their water content. The same dose of ethanol per unit of body weight can lead to very different blood ethanol levels in different individuals because of the large variations in proportions of fat and water in their bodies and the low lipid/water partition coefficient of ethanol. Women generally have a smaller volume for distribution of ethanol than men because of their higher percentage of body fat. 3 In this study, we observed that ethanol increased the calculated TE values of ALT (EC 2.6.1.2) and LDH (EC 1.1.1.27). The increase in TE value was related to the concentration of ethanol. Based on this observation, it can be concluded that ethanol causes false low results for the ALT and LDH parameters. Interestingly, we observed that ethanol did not interfere with tests for AST (EC 2.6.1.1), but it did interfere with tests for ALT. Both have a similar lysine residue in the active site and use pyridoxal-5-phosphate as their cofactor. 16 The LDH test was also affected similarly to ALT. In more detail, we have noticed that lactate is used as a substrate for both ALT and LDH activity measurements. In our opinion, ethanol directly competes with lactate, causing comparative inhibition. As the ethanol level increases, the magnitude of the observed negative bias is also increased in ALT and LDH measurement. There are dose-dependent negative interferences for ALT and LDH over ethanol ranges of 50 to 100 mg/dL, but the relationship between TE and ethanol levels is logarithmic. Therefore, the dose dependency deviates from linearity over 200 mg/dL (Figure 1) .
The calculated TE values for each of the ethanol-positive groups for direct bilirubin were over 20%. Direct bilirubin does not have a recommended aTE value in CLIA 88, but for total bilirubin this value is recommended to be below 20%. If the recommended aTE value for total bilirubin is taken as a reference, values over 20% observed in ethanol-positive groups represent a high total error. When total bilirubin and direct bilirubin are evaluated together, how can we explain the high TE level in direct bilirubin while it is low for total bilirubin? All other groups except for the ethanol-negative group had a higher CV value. This finding suggests the possibility of random error. Alcohol derivatives are used as accelerators in total bilirubin measurements. 17 As the name implies, direct bilirubin is the bilirubin fraction that is reacting directly with the diazo compounds. No accelerator is required for this measurement. We suppose that the exogenous ethanol in the plasma acts as an accelerator, causing interference in direct bilirubin measurements. But on the other hand, this event might be an artifact of the experiment, so repeating this experiment with samples with higher concentrations of direct bilirubin may provide more comprehensive information about the interference of ethanol.
In our study, we found that the bias and TE values calculated for urea in the ethanol-positive groups were higher than the recommended values. The TE was constant over ethanol levels ranging from 50 to 400 mg/dL, suggesting a constant negative interference on urea at these ethanol levels.
The fact that this study was done using in vitro conditions can be considered a limitation. During ethanol metabolism, other intermediates such as acetaldehyde are also released. Each of these may have interfering effects. Therefore, in vivo studies may provide more valuable information. In addition, although clinical chemistry autoanalyzers use similar measurement methods, the results of the study can be generalized, but this study's findings still are valid for the selected samples and methods.
We conclude that ethanol may cause interference in the measurement of some biochemical tests where the most prominent effect is observed for LDH and ALT. At the same time, we have come to the conclusion that ethanol may also interfere in direct bilirubin and urea measurements. This situation must be taken into account when measuring specimens taken from persons who are not particularly sure of hunger, especially in samples from the emergency department. It is necessary to collect additional data by repeating similar studies using other test methods and different brands of devices. 
